None listed
Conditions
Interventions
Dietary Supplement : Subject who voluntarily signs on the written informed consent form on visit 1 (week -1) is reviewed according to inclusion-exclusion criteria. The selected subject is randomly ass
Sponsors
Ajou University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects who voluntarily agree to participate and sign informed consent forms 2) Adults (20 = age < 65 years) 3) Subjects who have bad bowel movement 4) Subjects who have positive fecal calprotectin level
Exclusion criteria
Exclusion criteria: 1) Subject who consumes probiotics, prebiotics or antibiotics over 1 week consistently within 1 month 2) Subject who consumes high dietary fiber 3) Subject who has other underlying disease in digestive system currently or within two years 4) Subject who has intestinal surgery 5) Subject who has lactose intolerance 6) Subject who has diseases described below or takes related drugs: - severe liver disease, renal dysfunction, cardiovascular disease, immunological diseases and malignant tumors, etc 7) Subject who took the antiepileptic or antidiarrheal drugs within three days of his first visit 8) In the case of trip to area with epidemic parasitic diseases recently 9) Subject who has hypersensitivity to test food or ingredients of test food 10) Subject who has been in clinical trial within 1 month 11) Pregnant or lactating women or person who has pregnancy plan during the study 12) Any condition that the principal investigator believes may put the subjects at undue risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fecal analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Intestine symptom survey;Clinical pathological examination (blood test and urine test);Vital signs;Adverse event | — |
Countries
Korea, Republic of
Contacts
Public ContactKYUNAM KIM
Ajou University Hospital
Outcome results
None listed